Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Unusual Manifestations of Pediatric Neuromyelitis Optica.
Abstracts of the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. October 10-13, 2012. Lyon, France.
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
Embryonic stem cells in multiple sclerosis.
The Involvement of Calpain in CD4(+) T Helper Cell Bias in Multple Sclerosis.
Advances in the treatment of relapsing - Remitting multiple sclerosis.
(+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats.
Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD-L1.
Study of curcumin immunomodulatory effects on reactive astrocyte cell function.
Epstein-barr virus: the path from association to causality for a ubiquitous human pathogen.
A new model of cuprizone-mediated demyelination/remyelination.
The GSTP1 gene variant rs1695 is not associated with an increased risk of multiple sclerosis.
Remotely-supervised transcranial direct current stimulation (tDCS) for clinical trials: guidelines for technology and protocols.
Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder.
Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI.
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.
Randomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol.
The relationship between muscle pain and fatigue.
White matter disease: Hyaluronidase PH-20 digestion products inhibit remyelination in demyelinating lesions.
Acceptance of pain in neurological disorders: Associations with functioning and psychosocial well-being.
Combining two multiple sclerosis treatments has no clinical benefit, study finds.
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.
Pages
« first
‹ previous
…
423
424
425
426
427
428
429
430
431
…
next ›
last »